compounded semaglutide enforcement news FDA Warns About Versions of Ozempic and Wegovy What Patients Need to Know

Retatrutide adds GIP and glucagon receptor activation to the GLP-1 effects

doi: 10.1007/s00125-017-4354-8 132 SammsRJCoghlanMPSloopKWSammsRJCoghlanMPSloopKW

In the Ozempic trials for type 2 diabetes, approximately one in twelve participants reported diarrhoea

Chao AM et al

One study states, A wealth of evidence now demonstrates that a decline in cellular nicotinamide adenine dinucleotide (NAD+) is a feature of aging. So, going in the other direction, by boosting NAD+ in your body, our goal is to slow this aging process by providing your cells the resources they need to regenerate, rebuild, and maintain optimal health

We have taken a holistic approach to weight loss because we are committed to providing a comprehensive set of options so individuals and their providers can find a solution that is right for them